Scholarlink

Background <p>To explore the clinical characteristics of dabrafenib-associated uveitis and provide a basis for diagnosis and treatment.</p> Methods <p>The database was retrieved to collect reports of dabrafenib-associated uveitis and clinical data were collected for retrospective analysis.</p> Results <p>Twenty-six patients were included in the study, with a median age of 56&#xa0;years (range 30, 75). The onset time of uveitis was 3&#xa0;months (range 0.75, 96) after administration. The types of uveitis were pan-uveitis (38.5%), anterior uveitis (34.6%), posterior uveitis (15.4%), and intermediate uveitis (3.8%). Fifty percent of the patients were Vogt-Koyanagi-Harada disease-like uveitis. After discontinuation of dabrafenib and treatment with topical and systemic steroids, the symptoms of uveitis improved in all patients.</p> Conclusion <p>Patients are advised to have regular ophthalmology examinations during the use of dabrafenib. Timely administration of systemic or local corticosteroid treatment can significantly improve the symptoms of patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical features, treatment and outcomes of dabrafenib-associated uveitis

  • 期刊论文

  • 发表日期：

    2025年7月26日

查看全文
  • Jieqiong Liu,
  • Wei Sun,
  • Chunjiang Wang

摘要

Background

To explore the clinical characteristics of dabrafenib-associated uveitis and provide a basis for diagnosis and treatment.

Methods

The database was retrieved to collect reports of dabrafenib-associated uveitis and clinical data were collected for retrospective analysis.

Results

Twenty-six patients were included in the study, with a median age of 56 years (range 30, 75). The onset time of uveitis was 3 months (range 0.75, 96) after administration. The types of uveitis were pan-uveitis (38.5%), anterior uveitis (34.6%), posterior uveitis (15.4%), and intermediate uveitis (3.8%). Fifty percent of the patients were Vogt-Koyanagi-Harada disease-like uveitis. After discontinuation of dabrafenib and treatment with topical and systemic steroids, the symptoms of uveitis improved in all patients.

Conclusion

Patients are advised to have regular ophthalmology examinations during the use of dabrafenib. Timely administration of systemic or local corticosteroid treatment can significantly improve the symptoms of patients.